Finance

Beta
Lists
PGEN:NASDAQ
Precigen Inc
$3.58
-7.25%
(-0.28) 1D
$3.61
+0.84% (+0.030)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PGEN...
Open
$3.84
High
$3.88
Low
$3.53
Mkt. cap
1.28B
Avg. vol.
4.11M
Volume
5.33M
52-wk high
$5.46
52-wk low
$1.35
EPS
-$1.24
Beta
1.06
Shares outstanding
356.51M
No. of employees
160
Open
$3.84
High
$3.88
Low
$3.53
Mkt. cap
1.28B
Avg. vol.
4.11M
Volume
5.33M
52-wk high
$5.46
52-wk low
$1.35
EPS
-$1.24
Beta
1.06
Shares outstanding
356.51M
No. of employees
160
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to PGEN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PGEN in the last 3 months.
Highest
Current $3.58
$14.00 (+291.06%)
Average
$12.50 (+249.16%)
Lowest
$11.00 (+207.26%)
News stories
From sources across the web
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com
Last report
May 13, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.02 / -$0.02
0.00%miss
Revenue / Est. (USD)
23.25M / 20.80M
+11.79%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
856.00K
2.92M
4.56M
23.25M
Cost of goods sold
1.56M
13.41M
8.59M
8.20M
Cost of revenue
1.56M
13.41M
8.59M
8.20M
Research and development expenses
11.02M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.13M
23.99M
17.64M
21.05M
Operating expense
27.16M
23.99M
17.64M
21.05M
Total operating expenses
28.71M
37.40M
26.23M
29.25M
Operating income
-27.86M
-34.48M
-21.67M
-5.99M
Other non operating income
4.43M
-111.50M
60.00K
290.00K
EBT including unusual items
-26.64M
-146.34M
-23.50M
-7.93M
EBT excluding unusual items
-22.73M
-146.34M
-23.50M
-7.93M
Income tax expense
3.00K
-
-
-
Effective tax rate
-0.01%
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.64M
-146.34M
-23.50M
-7.93M
Net profit margin
-3,112.38%
-5,008.35%
-514.85%
-34.10%
Earnings per share
-0.08
-
-
-
Interest and investment income
696.00K
534.00K
1.07M
683.00K
Interest expense
-
-902.00K
-2.96M
-2.91M
Net interest expenses
696.00K
-368.00K
-1.90M
-2.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.23M
-33.68M
-20.53M
-4.90M
Gain or loss from assets sale
14.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer